Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06229834 · ClinicalTrials.gov registry record · NA
Chiropractic Care for Episodic Migraine
A NA study of Episodic Migraine, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06229834: Recruiting NA study of Episodic Migraine, sponsored by Brigham and Women's Hospital.
NCT06229834 is a NA study of Episodic Migraine that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 60 participants, below the 492-participant average among 13 other Episodic Migraine trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06229834, a NA study of Episodic Migraine, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Migraine, a chronic intermittent headache disorder, ranks in the top five causes of years lived with disability. One promising non-pharmacologic and integrative treatment for migraine may be chiropractic care due to the co-occurrence of migraine and musculoskeletal complaints. The goal of this application is to perform a pilot study of chiropractic care for episodic migraine to help inform the design of a future, full-scale pragmatic effectiveness trial.
Primary Outcome
Each site will be able to recruit 30 participants within 16 months
Conditions Studied
Interventions
- PROCEDURE Chiropractic Care
- BEHAVIORAL Headache Health Education
Study Locations (1)
Massachusetts
- Osher Center for Integrative Health, Mass General Brigham - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-03-22 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What NCT06229834 shows while recruiting
NCT06229834 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 492-participant average among 13 other Episodic Migraine trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Episodic Migraine appearing as the primary indexed condition, and to 2 interventions - of which Chiropractic Care is the first listed.
NCT06229834 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06229834 about?
NCT06229834 is a clinical study titled "Chiropractic Care for Episodic Migraine". Migraine, a chronic intermittent headache disorder, ranks in the top five causes of years lived with disability. One promising non-pharmacologic and integrative treatment for migraine may be chiropractic care due to the co-occurrence of migraine and musculoskeletal complaints. The goal of this appli...
What is the current status of trial NCT06229834?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-03-22. Estimated completion is 2027-04-30.
What conditions does trial NCT06229834 study?
This clinical trial studies the following conditions: Episodic Migraine.
What interventions are being tested in trial NCT06229834?
The interventions under investigation include: Chiropractic Care (PROCEDURE), Headache Health Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT06229834?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06229834 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Episodic Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06229834's enrollment target sits among peer trials
60 13th of 13 the lowest of 13 other Episodic Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Episodic Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine
COMPLETED · NA
-
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
RECRUITING · Phase 3
-
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
RECRUITING · Phase 3
-
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
RECRUITING
-
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
RECRUITING · Phase 2
-
Efficacy of Nerve Blocks for Episodic Migraine
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI